| Q33436735 | Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners study |
| Q33881449 | Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial |
| Q34386832 | Deciphering the epidemic synergy of herpes simplex virus type 2 (HSV-2) on human immunodeficiency virus type 1 (HIV-1) infection among women in sub-Saharan Africa |
| Q43530502 | Highly active anti-retroviral therapy in the prevention of mother-to-child transmission of HIV in rural Zimbabwe during the socio-economic crisis |
| Q49174465 | Host factors that influence mother-to-child transmission of HIV-1: genetics, coinfections, behavior and nutrition |
| Q36777844 | Interactions and management issues in HSV and HIV coinfection |
| Q37809608 | Issues of Prematurity and HIV Infection |
| Q37014624 | Population-level effect of HSV-2 therapy on the incidence of HIV in sub-Saharan Africa |
| Q37201714 | Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa |
| Q34430752 | Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV. |
| Q38169113 | TB and HIV in the Central African region: current knowledge and knowledge gaps |
| Q37991272 | The ongoing pursuit of a prophylactic HSV vaccine. |
| Q37116460 | Update on successes and challenges regarding mother-to-child transmission of HIV. |